Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Buy
65
AHCO Quote, Financials, Valuation and Earnings
Last price:
$9.96
Seasonality move
:
-1.26%
Day range:
$9.92 - $10.23
52-week range:
$7.11 - $11.63
Dividend yield:
0%
P/E ratio:
18.29x
P/S ratio:
0.42x
P/B ratio:
0.84x
Volume:
3.7M
Avg. volume:
1.1M
1-year change:
2.89%
Market cap:
$1.4B
Revenue:
$3.3B
EPS (TTM):
$0.55
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
AHCO
AdaptHealth Corp.
|
$793.9M | $0.04 | -2.82% | 0.78% | $13.25 |
|
AXGN
Axogen, Inc.
|
$57.2M | $0.07 | 17.4% | 556.06% | $35.44 |
|
ELMD
Electromed, Inc.
|
$17.8M | -- | 11.04% | -- | $36.00 |
|
IRIX
IRIDEX Corp.
|
$12.8M | -$0.12 | -2.72% | -18.18% | -- |
|
MYO
Myomo, Inc.
|
$10.8M | -$0.07 | -13.8% | -1168.66% | $5.00 |
|
STXS
Stereotaxis, Inc.
|
$9.2M | -$0.06 | 43.53% | -30.79% | $4.20 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
AHCO
AdaptHealth Corp.
|
$9.97 | $13.25 | $1.4B | 18.29x | $0.00 | 0% | 0.42x |
|
AXGN
Axogen, Inc.
|
$31.98 | $35.44 | $1.5B | -- | $0.00 | 0% | 7.09x |
|
ELMD
Electromed, Inc.
|
$28.62 | $36.00 | $238.7M | 30.79x | $0.00 | 0% | 3.82x |
|
IRIX
IRIDEX Corp.
|
$1.00 | -- | $17.2M | -- | $0.00 | 0% | 0.33x |
|
MYO
Myomo, Inc.
|
$0.93 | $5.00 | $35.8M | -- | $0.00 | 0% | 0.92x |
|
STXS
Stereotaxis, Inc.
|
$2.34 | $4.20 | $218.4M | -- | $0.00 | 0% | 6.90x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
AHCO
AdaptHealth Corp.
|
54.08% | 1.029 | 156.05% | 0.73x |
|
AXGN
Axogen, Inc.
|
35.99% | -0.858 | 8.25% | 2.56x |
|
ELMD
Electromed, Inc.
|
-- | 1.217 | -- | 4.58x |
|
IRIX
IRIDEX Corp.
|
50.55% | 0.834 | 18.81% | 1.03x |
|
MYO
Myomo, Inc.
|
45.68% | -2.855 | 35.87% | 1.94x |
|
STXS
Stereotaxis, Inc.
|
32.62% | 1.831 | 1.93% | 0.81x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
AHCO
AdaptHealth Corp.
|
$151.8M | $65.9M | 2.19% | 5.03% | 8.04% | $66.8M |
|
AXGN
Axogen, Inc.
|
$46M | $1.9M | -1.19% | -1.94% | 3.18% | $1.4M |
|
ELMD
Electromed, Inc.
|
$13.2M | $2.7M | 18.88% | 18.89% | 15.81% | -$98K |
|
IRIX
IRIDEX Corp.
|
$4M | -$1.4M | -54.1% | -155.93% | -11.3% | -$1.2M |
|
MYO
Myomo, Inc.
|
$6.4M | -$3.5M | -46.49% | -68.35% | -34.86% | -$2.9M |
|
STXS
Stereotaxis, Inc.
|
$4.1M | -$5.2M | -141.59% | -218.3% | -69.75% | -$4.2M |
AdaptHealth Corp. vs. Competitors
-
Which has Higher Returns AHCO or AXGN?
Axogen, Inc. has a net margin of 2.89% compared to AdaptHealth Corp.'s net margin of 1.18%. AdaptHealth Corp.'s return on equity of 5.03% beat Axogen, Inc.'s return on equity of -1.94%.
Company Gross Margin Earnings Per Share Invested Capital AHCOAdaptHealth Corp.18.51% $0.16 $3.5B AXGNAxogen, Inc.76.55% $0.01 $188.7M -
What do Analysts Say About AHCO or AXGN?
AdaptHealth Corp. has a consensus price target of $13.25, signalling upside risk potential of 32.9%. On the other hand Axogen, Inc. has an analysts' consensus of $35.44 which suggests that it could grow by 10.83%. Given that AdaptHealth Corp. has higher upside potential than Axogen, Inc., analysts believe AdaptHealth Corp. is more attractive than Axogen, Inc..
Company Buy Ratings Hold Ratings Sell Ratings AHCOAdaptHealth Corp.5 2 0 AXGNAxogen, Inc.7 0 0 -
Is AHCO or AXGN More Risky?
AdaptHealth Corp. has a beta of 1.768, which suggesting that the stock is 76.757% more volatile than S&P 500. In comparison Axogen, Inc. has a beta of 1.062, suggesting its more volatile than the S&P 500 by 6.241%.
-
Which is a Better Dividend Stock AHCO or AXGN?
AdaptHealth Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Axogen, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AdaptHealth Corp. pays -- of its earnings as a dividend. Axogen, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AHCO or AXGN?
AdaptHealth Corp. quarterly revenues are $820.3M, which are larger than Axogen, Inc. quarterly revenues of $60.1M. AdaptHealth Corp.'s net income of $23.7M is higher than Axogen, Inc.'s net income of $708K. Notably, AdaptHealth Corp.'s price-to-earnings ratio is 18.29x while Axogen, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AdaptHealth Corp. is 0.42x versus 7.09x for Axogen, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AHCOAdaptHealth Corp.0.42x 18.29x $820.3M $23.7M AXGNAxogen, Inc.7.09x -- $60.1M $708K
-
Which has Higher Returns AHCO or ELMD?
Electromed, Inc. has a net margin of 2.89% compared to AdaptHealth Corp.'s net margin of 12.65%. AdaptHealth Corp.'s return on equity of 5.03% beat Electromed, Inc.'s return on equity of 18.89%.
Company Gross Margin Earnings Per Share Invested Capital AHCOAdaptHealth Corp.18.51% $0.16 $3.5B ELMDElectromed, Inc.78.15% $0.25 $44.7M -
What do Analysts Say About AHCO or ELMD?
AdaptHealth Corp. has a consensus price target of $13.25, signalling upside risk potential of 32.9%. On the other hand Electromed, Inc. has an analysts' consensus of $36.00 which suggests that it could grow by 25.79%. Given that AdaptHealth Corp. has higher upside potential than Electromed, Inc., analysts believe AdaptHealth Corp. is more attractive than Electromed, Inc..
Company Buy Ratings Hold Ratings Sell Ratings AHCOAdaptHealth Corp.5 2 0 ELMDElectromed, Inc.4 0 0 -
Is AHCO or ELMD More Risky?
AdaptHealth Corp. has a beta of 1.768, which suggesting that the stock is 76.757% more volatile than S&P 500. In comparison Electromed, Inc. has a beta of 0.259, suggesting its less volatile than the S&P 500 by 74.113%.
-
Which is a Better Dividend Stock AHCO or ELMD?
AdaptHealth Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Electromed, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AdaptHealth Corp. pays -- of its earnings as a dividend. Electromed, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AHCO or ELMD?
AdaptHealth Corp. quarterly revenues are $820.3M, which are larger than Electromed, Inc. quarterly revenues of $16.9M. AdaptHealth Corp.'s net income of $23.7M is higher than Electromed, Inc.'s net income of $2.1M. Notably, AdaptHealth Corp.'s price-to-earnings ratio is 18.29x while Electromed, Inc.'s PE ratio is 30.79x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AdaptHealth Corp. is 0.42x versus 3.82x for Electromed, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AHCOAdaptHealth Corp.0.42x 18.29x $820.3M $23.7M ELMDElectromed, Inc.3.82x 30.79x $16.9M $2.1M
-
Which has Higher Returns AHCO or IRIX?
IRIDEX Corp. has a net margin of 2.89% compared to AdaptHealth Corp.'s net margin of -12.6%. AdaptHealth Corp.'s return on equity of 5.03% beat IRIDEX Corp.'s return on equity of -155.93%.
Company Gross Margin Earnings Per Share Invested Capital AHCOAdaptHealth Corp.18.51% $0.16 $3.5B IRIXIRIDEX Corp.32.15% -$0.09 $9.5M -
What do Analysts Say About AHCO or IRIX?
AdaptHealth Corp. has a consensus price target of $13.25, signalling upside risk potential of 32.9%. On the other hand IRIDEX Corp. has an analysts' consensus of -- which suggests that it could grow by 100%. Given that IRIDEX Corp. has higher upside potential than AdaptHealth Corp., analysts believe IRIDEX Corp. is more attractive than AdaptHealth Corp..
Company Buy Ratings Hold Ratings Sell Ratings AHCOAdaptHealth Corp.5 2 0 IRIXIRIDEX Corp.0 0 0 -
Is AHCO or IRIX More Risky?
AdaptHealth Corp. has a beta of 1.768, which suggesting that the stock is 76.757% more volatile than S&P 500. In comparison IRIDEX Corp. has a beta of 0.652, suggesting its less volatile than the S&P 500 by 34.842%.
-
Which is a Better Dividend Stock AHCO or IRIX?
AdaptHealth Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. IRIDEX Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AdaptHealth Corp. pays -- of its earnings as a dividend. IRIDEX Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AHCO or IRIX?
AdaptHealth Corp. quarterly revenues are $820.3M, which are larger than IRIDEX Corp. quarterly revenues of $12.5M. AdaptHealth Corp.'s net income of $23.7M is higher than IRIDEX Corp.'s net income of -$1.6M. Notably, AdaptHealth Corp.'s price-to-earnings ratio is 18.29x while IRIDEX Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AdaptHealth Corp. is 0.42x versus 0.33x for IRIDEX Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AHCOAdaptHealth Corp.0.42x 18.29x $820.3M $23.7M IRIXIRIDEX Corp.0.33x -- $12.5M -$1.6M
-
Which has Higher Returns AHCO or MYO?
Myomo, Inc. has a net margin of 2.89% compared to AdaptHealth Corp.'s net margin of -36.3%. AdaptHealth Corp.'s return on equity of 5.03% beat Myomo, Inc.'s return on equity of -68.35%.
Company Gross Margin Earnings Per Share Invested Capital AHCOAdaptHealth Corp.18.51% $0.16 $3.5B MYOMyomo, Inc.63.84% -$0.09 $26.9M -
What do Analysts Say About AHCO or MYO?
AdaptHealth Corp. has a consensus price target of $13.25, signalling upside risk potential of 32.9%. On the other hand Myomo, Inc. has an analysts' consensus of $5.00 which suggests that it could grow by 436.19%. Given that Myomo, Inc. has higher upside potential than AdaptHealth Corp., analysts believe Myomo, Inc. is more attractive than AdaptHealth Corp..
Company Buy Ratings Hold Ratings Sell Ratings AHCOAdaptHealth Corp.5 2 0 MYOMyomo, Inc.4 0 0 -
Is AHCO or MYO More Risky?
AdaptHealth Corp. has a beta of 1.768, which suggesting that the stock is 76.757% more volatile than S&P 500. In comparison Myomo, Inc. has a beta of 1.026, suggesting its more volatile than the S&P 500 by 2.583%.
-
Which is a Better Dividend Stock AHCO or MYO?
AdaptHealth Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Myomo, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AdaptHealth Corp. pays -- of its earnings as a dividend. Myomo, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AHCO or MYO?
AdaptHealth Corp. quarterly revenues are $820.3M, which are larger than Myomo, Inc. quarterly revenues of $10.1M. AdaptHealth Corp.'s net income of $23.7M is higher than Myomo, Inc.'s net income of -$3.7M. Notably, AdaptHealth Corp.'s price-to-earnings ratio is 18.29x while Myomo, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AdaptHealth Corp. is 0.42x versus 0.92x for Myomo, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AHCOAdaptHealth Corp.0.42x 18.29x $820.3M $23.7M MYOMyomo, Inc.0.92x -- $10.1M -$3.7M
-
Which has Higher Returns AHCO or STXS?
Stereotaxis, Inc. has a net margin of 2.89% compared to AdaptHealth Corp.'s net margin of -86.59%. AdaptHealth Corp.'s return on equity of 5.03% beat Stereotaxis, Inc.'s return on equity of -218.3%.
Company Gross Margin Earnings Per Share Invested Capital AHCOAdaptHealth Corp.18.51% $0.16 $3.5B STXSStereotaxis, Inc.54.94% -$0.07 $17.1M -
What do Analysts Say About AHCO or STXS?
AdaptHealth Corp. has a consensus price target of $13.25, signalling upside risk potential of 32.9%. On the other hand Stereotaxis, Inc. has an analysts' consensus of $4.20 which suggests that it could grow by 79.49%. Given that Stereotaxis, Inc. has higher upside potential than AdaptHealth Corp., analysts believe Stereotaxis, Inc. is more attractive than AdaptHealth Corp..
Company Buy Ratings Hold Ratings Sell Ratings AHCOAdaptHealth Corp.5 2 0 STXSStereotaxis, Inc.3 0 0 -
Is AHCO or STXS More Risky?
AdaptHealth Corp. has a beta of 1.768, which suggesting that the stock is 76.757% more volatile than S&P 500. In comparison Stereotaxis, Inc. has a beta of 1.472, suggesting its more volatile than the S&P 500 by 47.244%.
-
Which is a Better Dividend Stock AHCO or STXS?
AdaptHealth Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Stereotaxis, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AdaptHealth Corp. pays -- of its earnings as a dividend. Stereotaxis, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios AHCO or STXS?
AdaptHealth Corp. quarterly revenues are $820.3M, which are larger than Stereotaxis, Inc. quarterly revenues of $7.5M. AdaptHealth Corp.'s net income of $23.7M is higher than Stereotaxis, Inc.'s net income of -$6.5M. Notably, AdaptHealth Corp.'s price-to-earnings ratio is 18.29x while Stereotaxis, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AdaptHealth Corp. is 0.42x versus 6.90x for Stereotaxis, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income AHCOAdaptHealth Corp.0.42x 18.29x $820.3M $23.7M STXSStereotaxis, Inc.6.90x -- $7.5M -$6.5M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
1
LW alert for Dec 20
Lamb Weston Holdings, Inc. [LW] is down 25.96% over the past day.
Buy
54
BMRN alert for Dec 20
BioMarin Pharmaceutical, Inc. [BMRN] is up 17.79% over the past day.
Buy
82
RKLB alert for Dec 20
Rocket Lab Corp. [RKLB] is up 17.72% over the past day.
